arrow
T

Tommaso Cavalleri

irccs istituto nazionale tumori milano
H指数:13
被引数:645

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASO Visual Abstract: Mesenteric Peritonectomy as the Seventh Peritonectomy Technique in Cytoreductive Surgery for Peritoneal Surface Malignancies: a Propensity Score-Matched Analysis

ASO可视化摘要:在细胞减灭术治疗腹膜表面恶性肿瘤中,肠系膜腹膜切除术作为第七种腹膜切除术技术:一项倾向性评分匹配分析

2026-09-300
PRE
Comparative oncological efficacy of chemotherapy, cytoreductive surgery with or without HIPEC in recurrent ovarian cancer: A network meta-analysis

化疗、减瘤术(含或不含HIPEC)治疗复发性卵巢癌的肿瘤学疗效比较:一项网络Meta分析

EJSO
IF2.9
2026-09-110
PRE
Tailoring HIPEC with Patient-Derived Organoids in Colorectal Peritoneal Metastases: Results from the First Stage of the Prospective Phase II OrganoHIPEC Clinical Trial (Clinicaltrials.gov NCT06057298)

利用患者源性类器官定制腹腔热灌注化疗(HIPEC)治疗结直肠癌腹膜转移:前瞻性II期OrganoHIPEC临床试验第一阶段的成果(Clinicaltrials.gov NCT06057298)

Cancers
IF4.4
2026-08-280
OA
The Inflammatory Biomarkers Prognostic Index (IBPI) obtained from standard preoperative blood tests predicts postoperative complications in patients undergoing pelvic exenteration for locally recurrent rectal cancer

通过标准术前血液检测获得的炎症生物标志物预后指数(IBPI)可预测接受盆腔廓清术治疗的局部复发直肠癌患者的术后并发症

2026-04-180
PRE
Colorectal carcinoma peritoneal metastases-derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench-to-bedside (vol 43, 132, 2024)
2024-06-110
OAAI
Colorectal carcinoma peritoneal metastases-derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench-to-bedside
2024-05-026
OAAI
Tumor-associated macrophages and risk of recurrence in stage III colorectal cancer

肿瘤相关巨噬细胞与 ⅲ 期结直肠癌复发风险

2022-03-2315
OAAI
Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer
2020-11-2325
OAAI
Susceptibility to particle health effects, miRNA and exosomes: rationale and study protocol of the SPHERE study
2014-11-0444
OAAI